Journal of Nanomaterials

Journal of Nanomaterials / 2020 / Article
Special Issue

Nanomaterials in Bone Tissue Engineering

View this Special Issue

Erratum | Open Access

Volume 2020 |Article ID 7373065 | https://doi.org/10.1155/2020/7373065

Jihang Yao, Yilong Wang, Wendi Ma, Wenying Dong, Mei Zhang, Dahui Sun, "Erratum to “Dual-Drug-Loaded Silk Fibroin/PLGA Scaffolds for Potential Bone Regeneration Applications”", Journal of Nanomaterials, vol. 2020, Article ID 7373065, 2 pages, 2020. https://doi.org/10.1155/2020/7373065

Erratum to “Dual-Drug-Loaded Silk Fibroin/PLGA Scaffolds for Potential Bone Regeneration Applications”

Received21 Jul 2020
Accepted22 Jul 2020
Published01 Sep 2020

In the article titled “Dual-Drug-Loaded Silk Fibroin/PLGA Scaffolds for Potential Bone Regeneration Applications” [1], there was an error in Figure 10. The corrected figure is shown below and is listed as Figure 1.

The error was introduced during the production process of the article, and Hindawi apologises for causing this error.

References

  1. J. Yao, Y. Wang, W. Ma, W. Dong, M. Zhang, and D. Sun, “Dual-drug-loaded silk fibroin/PLGA scaffolds for potential bone regeneration applications,” Journal of Nanomaterials, vol. 2019, Article ID 8050413, 16 pages, 2019. View at: Publisher Site | Google Scholar

Copyright © 2020 Jihang Yao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views98
Downloads27
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.